Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib + Thalidomide + Dexamethasone in RRMM
NCT02410694Phase 2Completed
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Start
- Apr 2015
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of ixazomib in multiple myeloma (MM), sponsored by Arbeitsgemeinschaft medikamentoese Tumortherapie. Started Apr 2015; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02410694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02410694.